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The family of EF-hand calcium binding proteins is composed of more than 250 members.
In search for other neuronal markers, we studied the expression pattern of Necab-1, -2 and
-3 in the Ammons horn of adult mice at the gene- and protein levels using in-situ
hybridization and immunohistochemistry. The genes for the three Necab's were expressed
in speciﬁc, non-overlapping areas of the hippocampus. A minority of the Necab-positive
interneurons were GABA-ergic, and they virtually never coexpressed one of the classical
calcium binding proteins (calretinin, calbindin D-28k and parvalbumin). Necab's are
promising new neuronal markers in the brain.
1. Introduction
The EF-hand family Ca2+-binding proteins parvalbumin, cal-
bindin D-28k and calretinin are classic phenotypic markers of
terminally differentiated, non-overlapping subclasses of neu-
rons. Secretagogin (Mulder et al., 2009) is a recent addition
to the ﬁeld of these useful tags of neuronal subpopulations.
These markers are favorite tools in deﬁning cell types,
Abbreviations: ne: not expressed; X: expressed; OB: olfactory bulb; gr: granular layer; gl: glomerular layer; CTX: cortex;
Diverse: AON: anterior olfactory nucleus; isl: islands of Calleja; ACB: nucleus accumbens; CP: caudoputamen; TRS: triangular
nucleus of septum; OT: olfactory tubercle; TT: tenia tecta (dorsal and ventral parts); LS: lateral septal nucleus; PIR: piriform area;
TH: thalamus; PVT: paraventricular nucleus of the thalamus; LP/LD: lateral posterior/dorsal nucleus of the thalamus; CM: central
medial nucleus of the thalamus; RH: rhomboid nucleus; MD/IMD: mediodorsal/intermediodorsal nucleus of the thalamus;
AD: anterodorsal nucleus of the thalamus; VN: ventral nucleus of the thalamus; HPF: hippocampal formation;
HYP: hypothalamus; MM: medial mammillary nucleus; MB: midbrain; SC: superior colliculus; VTA: ventral tegmental area;
SN: substantia nigra; RN: red nucleus; DR: dorsal nucleus raphe; MEV: midbrain trigeminal nucleus; P: pons; PB: parabrachial
nucleus; PG: pontine gray; TRN: tegmental reticular nucleus; PSV: principal sensory nucleus of the trigeminal; PRN: pontine
reticular nucleus; V: motor nucleus of trigeminal; CBX: cerebellar cortex; Pu: Purkinje layer; Gr: granular layer; MY: medulla;
VII: facial motor nucleus; XII: hypoglossal nucleus; IO: inferior olivary complex; SPV: spinal nucleus of the trigeminal; LRN: lateral
reticular nucleus; MARN: magnocellular reticular nucleus.
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functional systems and targets for diverse pathologies (Schafer
and Heizmann, 1996).
The Human Genome Project has revealed that the family
of EF-hand calcium binding proteins is much larger than
thought. Approximately 250 genes coding for proteins har-
boring one or more EF-hands have been revealed. A glance at
the distribution of the corresponding mRNA's in the Allen-
Database suggests that many of these proteins occur in
unique patterns of distribution. Therefore, in addition to the
classic four “musketeers” (e.g. calbindin D-28k, calretinin,
parvalbumin and secretagogin), other members of the family
of EF-hand calcium binding proteins could be interesting
markers in health and disease.
In a project aiming at locating precisely a large number of
these proteins in the brain, we ﬁrst choose to study the
distribution of the neuronal calcium-binding proteins
Necab-1, Necab-2 and Necab-3. Only four articles on these
proteins exist in the literature, and the ﬁrst description by
Sugita et al. (Sugita et al., 2002) already contained information
on the immunohistochemical distribution of Necab-1. Accord-
ing to this study, Necab-1 is expressed mainly in cortical layer
4 pyramidal cells, pyramidal cells of the CA2-region of the
hippocampus as well as interneurons therein. In a subpopula-
tion of interneurons, Necab-1 colocalizes with calbindin D-28k
in the same cell (Sugita et al., 2002). Comparing these results
with the in-situ hybridization images in the Allen-database
(http://mouse.brain-map.org/), we remarked certain discrepan
cies. The mRNA for Necab-1, for example, does not seem to be
expressed in the CA2-region of the hippocampus.
The purpose of the present study was therefore to map the
distribution of the three Necabs in the hippocampus of adult
mice at the gene- and protein-expression levels using in-situ
hybridization and immunohistochemistry. Attention was
given to compare their distribution with that of GABA-
positive interneurons, particularly those expressing the three
classic Ca2+-binding proteins calbindin D-28k, calretinin and
parvalbumin.
2. Results
2.1. General
We limited our observations to the hippocampus and the
hilus of the dentate gyrus. In each case ∼100 cells labeled by
in-situ hybridization or by immunohistochemistry were
counted in adjacent sections to determine the percentage of
co-existence.
At the mRNA-level, only the Necab-1 and Necab-2 probes
gave satisfactory results, comparable to what expected from
the pattern gleaned from the Allen-Database (http://mouse.
brain-map.org/). The Necab-3 probe stained with a high
background under a multitude of different conditions. The
immunohistochemical staining with Necab-2 and Necab-3
antisera gave similar distribution patterns (Table 1).
2.2. Necab-1
Cells expressing the mRNA for Necab-1 were scattered
throughout the cell-poor layers of the ammons horn and
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the hilus of the dentate gyrus (Fig. 1). No expression of the
mRNA for Necab-1 was observed in either the pyramidal-cell
layer of CA1-CA3 or the dentate-granule-cell layer.
Necab-1 mRNA, co-existed with GAD-1 mRNA in some
neurons (less than 10%) (Fig. 1A and B). No co-existence with
calretinin (Fig. 1F), calbindin D-28k or parvalbumin (not
shown), was observed. Necab1-positive interneurons were
more frequently found than Necab-2-postive ones.
2.3. Necab-2
The mRNA for Necab-2 was highly enriched in the pyramidal-
cell layer of the CA2 region (Fig. 2A and C) and in some rare
interneurons in the rest of the hippocampus.
The immunohistochemical analysis revealed this pattern
of distribution to be imitated at the protein level (Fig. 3).
No evidence for the co-existence of Necab-2 with calretinin
(not shown), calbindin D-28k or parvalbumin (Fig. 3A, D and F)
at the mRNA or protein level was found.
2.4. Necab-3
The mRNA for Necab-3 was expressed everywhere in the
hippocampus, with a slight preferences for certain cells (e.g.
dentate gyrus and some interneurons, Fig. 4B).
The Necab-3 antiserum stained the molecular layer of the
dentate gyrus and the CA2 zone and rare interneurons. The
Necab-3-positive interneurones did not co-express calretinin,
calbindin D-28k or parvalbumin (Fig. 4).
Necab-1 Gad 1
LP
Hb
Gad 1Necab-1
**
**
Calb2Necab-1
Fig. 1 – (A and B) In-situ hybridization of mRNA for Necab-1 and Gad1: Necab-1 positive cells are located within the stratum
lacunosum moleculare, the stratum radiatum and the stratum oriens of the hippocampus, as well as in the hilus of the dentate
gyrus. Only a few (∼10%) of the scattered cells expressing the mRNA for Necab-1 (arrows) also express GAD-mRNA. Neurons
within the nucleus of the thalamus (LP) express high levels of the mRNA for Necab 1, whereas GADmRNA is rich in the
habenular nuclei (Hb). (C and D) Higher magniﬁcation of A, respectively to the other section ﬂanking the section depicted in A.
Only one out of the approximately 20 cells in this ﬁeld of view expresses the mRNA's for Necab-1 and GAD1. (E and F) Necab-1
and Calb1 mRNAs are not expressed in the same cells of the hippocampus (arrows), but may co-exist in thalamic projection
neurons.
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CA2–PvalbNecab-2 - CA2/3
Calb1Necab-2
CA2
Calb1Necab-2
Fig. 2 – In-situ hybridization for Necab-2 mRNA (A, C and E) compared to the distribution of the mRNA for parvalbumin (Pvalb;
B) and calbindin D-28k (Calb1, D and F). (A–C) The mRNA for Necab 2 is highly expressed within pyramidal cells of the CA2
region (brackets in A and C). A scattering of positively-stained cells is apparent In the Pvalb-section (arrows in B). (D–F) Calb1
mRNA is enriched in the dentate gyrus (arrow in D) and occurs in scattered neurons in various layers of the hippocampus.
Coexistence with Necab1 was never observed (E and F).
CA2
α-Necab-2 α-Necab-2
CA2
mo
Fig. 3 – (A) Immunohistochemical revelation of the Necab-2 protein. Positive reactivity is observed within pyramidal cells of
the CA2 region (bracket). The molecular layer of the dentate gyrus (mo) is also stained (arrows). (B) Higher magniﬁcation of A.
Positive reaction within the dendrites of pyramidal cells in the CA2 region.
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3. Discussion
In-situ hybridization revealed a restricted and, for the most
part, non-overlapping expression of the mRNAs for Necab-1
and Necab-2 in the hippocampus of adult mice, whereas the
results for Necab-3 were difﬁcult to categorize. In the Allen-
Database, Necab-3 is shown to be expressed in the granular
layer of the dentate gyrus and in the hippocampal CA3 zone.
Necab 1 has been shown by afﬁnity chromatography to
interact with the C2-domain of synaptotagmin—a synaptic-
vesicle protein that is involved in calcium-dependent exocytosis
(Canela et al., 2009). Our data pertaining to the in-situ hybridiza-
tion of Necab 1 are at variance with previously-reported immu-
nohistochemical ﬁndings (Sugita et al., 2002) revealing intense
immunoreactivity within pyramidal cells of the CA2 region. We
observed mRNA for Necab 1 only within interneurons - as is
reported in the Allen-Database - and never in the CA2 region. We
presume that in the earlier study, the antibody against Necab-1
cross-reacted with the Necab-2 protein that is expressed within
the pyramidal cells of the CA2 region (see our Fig. 2B and C). This
supposition is supported by the observation that in the earlier
study, immunoblotting experiments revealed the antibody
against Necab 1 to cross-react with Necab-2 and Necab-3
proteins in Cos cells that had been transfected with vectors for
their expression (Sugita et al., 2002).
Necab-2 has been reported to be a downstream target of Pax6
—a transcription factor involved in the development of the eye
and the brain. In the development of the retina, it forms part of a
signal-transduction pathway (Bernier et al., 2001). Necab-2 also
interacts with the adenosine A2-receptor and the glutamate-5
receptor in a calcium dependent manner (Canela et al., 2007;
Canela et al., 2009). In both cases, this interaction leads to a
downregulation of the cell-surface receptors and a modulation of
their activities (Canela et al., 2007; Canela et al., 2009). Our data of
in-situ hybridization and immunohistochemistry of Necab-2 con-
ﬁrm the staining in the basal ganglia as published by others
(Canela et al., 2007), but not the reaction of the CA1 pyramidal
cells (Canela et al., 2009). In the hippocampus, only the CA2
pyramidal cells and scattered cells expressed the Necab 2 gene,
consistent with results of the Allen Database.
Necab 3 may be a substrate of Nek2 and play thus a role in the
Golgi apparatus (Yoo et al., 2004), whereas other task in connec-
tion with β-amyloid (Yoo et al., 2004) could not be conﬁrmed
(Sugita et al., 2002). The hybridization in the granule cells of the
dentate gyrus and the pyramidal cells of the CA3 region, as visible
in the Allen-Database, was difﬁcult to reproduce.
The antiserum against Necab-2 highlights the CA2 pyramidal
cells, but also stains dentate granule cells and some scattered
interneurons. This pattern is similar to that of the Necab-3
antiserum. Being directed against recombinant proteins which
share ∼50% sequence homologies, they probably cross-react with
the other two members of this family. Therefore, immunohisto-
chemical studies of the distribution of Necab's in the brain may
be less reliable than in-situ hybridization experiments.
4. Experimental Procedures
4.1. In-situ hybridization
The brains were dissected from 7 deeply anaesthetized Ketalar
[(Parke-Davis) 75 mg/kg of body weight] and Xylazine [(Streuli)
CA2/3 CA2/3 Necab3-ISHCB1-ISH
CA2/3CA2/3 Pvalb-ISH Necab3-ISH
Fig. 4 – In-situ hybridization for Necab-3 mRNA (B and D) compared to the distribution of the mRNA for calbindin D-28k
(Calb1, A) and parvalbumin (Pvalb; C). Interneurons positive for parvalbumin or calbindin D-28k (A and C) never express the
mRNA for Necab3 (B and D).
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10mg/kg of body weight], adult female andmale mice (C57 BI/6)
and immediately frozen on dry ice. They were then stored at
70 1C until use. Cryosections were prepared from the frozen
brains. In-situ hybridization was performed as recommended
by Roche (DIG application manual for nonradioactive in-situ hybri-
dization, Roche Applied Science, 3rd Edition). To improve the
speciﬁcity of the gene-expression patterns, several of the
parameters were modiﬁed (incubation temperature: 60 1C, incu-
bation time: 16 h/concentration of the RNA probe: 1/100, con-
centration of proteinase K: 2 ml/ml). The digoxigenin-labeled
RNA-probes were prepared following the polymerase-chain-
reaction-based strategy (http://www.brain-map.org). The RNA
of adult-mouse brains (Zyagen) was reverse transcribed using a
commercial kit (Applied Biosystems). The polymerase
chain-reaction was performed under standard conditions. The
primers used to generate speciﬁc ISH probes for each of the
genes tested were the same as those described in the Allen
Brain Atlas Database (http://www.brain-map.org):
Necab-1 (probe size: 605 bp):
Forward: GACTGAATGTTAGGATCTGGGC
Reverse: AGCACCTGACCAGGACTATGAT
Necab-2 (probe size: 617 bp):
Forward: TACCATCGATTCAGACAACACC
Reverse: AGGTACTGTCTCAGGGAATCCA
Necab-3 (probe size: 693 bp):
Forward: GCTGCTACATGAACTTCACAGG
Reverse: TAGACTGAGTTGGCCTAGCCTC
Gad1 (probe size: 982 bp):
Forward: TGTGCCCAAACTGGTCCT
Reverse: TGGCCGATGATTCTGGTT
Calb1 (probe size: 579 bp):
Forward: GAACTATTCAGGATGTGTGGCA
Reverse: GGGCTATGGTCATACTCTCTGG
Calb2 (probe size: 893 bp):
Forward: GATGCTGACGGAAATGGG
Reverse: CCCTACCAGCCACCCTCT
Pvalb (probe size: 823 bp):
Forward: TCTGCTCATCCAAGTTGCAG
Reverse: TCCTGAAGGACTCAACCCC
The forward and reverse primers were ﬂanked by T3- and
SP6-RNA polymerase core-promoter sequences, respectively
(T3: AATTAACCCTCACTAAAGG; SP6: GCGATTTAGGTGACAC
TATAG).
In addition, 2 mice were deeply anesthetized, and per-
fused transcardially with 0.9% NaCl, followed by 4% parafor-
maldehyde in 0.1 M phosphate buffer, pH 7.2, postﬁxed
overnight and embedded in parafﬁn. 3 μm thin sections were
incubated with the same probes as above and revealed with
the Ventana-Discovery system. The procedure involved using
alkaline-phosphatase labeled anti-DIG. Details of the method
have been recently published (Girard et al., 2011). Different
probes were incubated with adjacent sections, so that the
gene of interest was ﬂanked by two identical control probes:
for example: Gad1/Necab-1/Gad-1 or Pvalb/Necab-2/Pvalb, etc.
4.2. Immunohistochemistry
A polyclonal antibody against Necab 2 was kindly provided by
Dr. Francisco Ciruela (University of Barcelona, Spain) (Canela
et al., 2007) and one against Necab 3 by Dr. Kunsoo Rhee,
South Korea (Yoo et al., 2004).
Polyclonal antibodies against calbindin D-28k, parvalbu-
min and calretinin were received from Swant (Marly, Switzer-
land). These antibodies and the immunhistochemical
technique have been described previously (Gerig and Celio
2007; Meszar et al., 2012).
5. Conclusion
The three Necab-proteins appear to be involved in diverse
activities, including the calcium-dependent activation of
target proteins (Canela et al., 2007; Canela et al., 2009),
calcium-buffering (Canela et al., 2009; Sugita et al., 2002)
and self-regulation via calcium binding (Canela et al., 2007;
Canela et al., 2009). The ﬁnding that each of the genes for
the three Necab-isoforms are expressed in speciﬁc regions
of the hippocampus, and that together their expression
embraced most of its expanse, indicates that notwithstand-
ing their structural similarities, the three calcium-binding
proteins might have different functional roles in this part of
the brain.
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